Sign In
Buy VTGN
$0.229
-0.0108 (-4.50%)
At Close: Jul 17, 2026
VTGN Stock Price: 9.3% Increase Explanation
10:35pm, Sunday, 23'rd May 2021
The stock price of Vistagen Therapeutics Inc (NASDAQ: VTGN) increased by 9.3% on Friday, May 21. This is why it happened.
5 Penny Stocks Analysts Say To Buy With Targets Up To 219% Right Now
07:45pm, Sunday, 23'rd May 2021
Analysts say these are penny stocks to buy right now & have bullish targets to back it up. The post 5 Penny Stocks Analysts Say To Buy With Targets Up To 219% Right Now appeared first on Penny Stocks
Vistagen Therapeutics (VTGN) Stock: Over 14% Increase Pre-Market Explanation
06:13am, Thursday, 20'th May 2021
The stock price of Vistagen Therapeutics Inc (NASDAQ: VTGN) increased by over 14% pre-market. This is why it happened.
Hot Penny Stocks to Watch; Is it Time to Buy The Biotech Dip?
11:40am, Thursday, 29'th Apr 2021
Penny stocks present opportunities to buy the dip often; is that the case with these biotech stocks? The post Hot Penny Stocks to Watch; Is it Time to Buy The Biotech Dip?
Penny Stocks Watchlists and How to Make One
04:48pm, Wednesday, 28'th Apr 2021
Penny stock watchlists? Why they're not as complicated as they seem The post Penny Stocks Watchlists and How to Make One appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStock
Novel Anxiety and Depression Approach by VistaGen Therapeutics
09:33am, Tuesday, 27'th Apr 2021
The COVID-19 pandemic has exacerbated mental health issues and is triggering new conditions for people already suffering from mental illnesses and substance abuse. Social anxiety disorder (SAD) is o
VistaGen: Phase 2 Success In Anxiety Disorder, Phase 3 To Begin
08:00am, Sunday, 25'th Apr 2021
VistaGen has had a tumultuous history, but recent trials have seen success. They may start phase 3 trials for PH94B in May.
VistaGen Therapeutics to Participate in Upcoming Investor Conferences in March
07:46am, Tuesday, 16'th Mar 2021
SOUTH SAN FRANCISCO, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company committed to developing and commercializing a new generation of medici
VistaGen's PH10 Nasal Spray Demonstrates Different Mechanism of Action from Benzodiazepines in Preclinical Study
08:30am, Thursday, 11'th Mar 2021
PH10 may have stand-alone potential to displace current oral antidepressants in the drug treatment paradigm for depression disorders PH10 may have stand-alone potential to displace current oral antide
VTGN Stock Price Increases Over 13% Pre-Market: Why It Happened
07:09am, Thursday, 18'th Feb 2021
The stock price of Vistagen Therapeutics Inc (NASDAQ: VTGN) has increased by over 13% pre-market as of 7:01 AM ET. This is why it happened.
Multiple clinical studies anticipated to launch in Calendar 2021, notably pivotal Phase 3 clinical studies of PH94B as a potential acute treatment of anxiety in adults with social anxiety disorder (SA
VistaGen: Patience Could Lead To Significant Upside
01:07am, Sunday, 24'th Jan 2021
VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing a generation of novel medicines for anxiety, depression, and other central nervous system disorders, pri
Dr. Louis Monti, VistaGen's Newly-Appointed Vice President, Translational Medicine, and Dr. Michael Liebowitz, VistaGen CNS Clinical and Regulatory Advisory Board Member, Collaborate on Review Dr. Lou
VistaGen Therapeutics Announces Closing of $100 Million Underwritten Public Offering
04:01pm, Tuesday, 22'nd Dec 2020
SOUTH SAN FRANCISCO, Calif., Dec. 22, 2020 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc. (NASDAQ: VTGN) (“VistaGen”), a biopharmaceutical company committed to developing a new generation of me
Why BioCryst, VistaGen And Teladoc Are Moving Today
12:23pm, Tuesday, 22'nd Dec 2020
VistaGen Therapeutics (NASDAQ: VTGN) shares are trading higher after Maxim raised its price target on the stock from $3 to $5. VistaGen Therapeutics is a biotechnology firm.
